Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Gastrointestinal Disorders (GID), Respiratory Diseases, Smoking Cessation, and Others), Product (Software and Devices), and Sales Channel (Business-to-business [B2B] and Business-to-consumers [B2C]): Global Opportunity Analysis and Industry Forecast, 2017 - 2025
- Published Date: 2020-10-18
- Report ID: 3204
- Pages: 225
-
Format:
The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025, registering a CAGR of 20.5% during the forecast period. Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.
Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market. In addition, increasing need to control healthcare costs supplements the market growth. However, lack of awareness regarding the availability of smartphone applications, especially in the developing countries, acts a major deterrent to the market growth. Conversely, high growth potential in the developing markets is expected to offer significant opportunities for the players operating in this market.
The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. On the basis of product, it is classified into software and devices. By sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, the business - to - business (B2B) segment is categorized into employers, healthcare providers, and others. Depending on business-to-consumers, the market is fragmented into patients and caregivers. Regionally, it is analyzed across North America, Europe, Asia - Pacific, and LAMEA.
Key benefits for Digital Therapeutics Market :
The study provides an in-depth analysis of the global digital therapeutics market along with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2017 to 2025 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.
Digital Therapeutics Key market segments :
By Application
Diabetes
Obesity
Cardiovascular Disease (CVD)
Central Nervous System (CNS) Disease
Respiratory Disease
Smoking Cessation
Gastrointestinal Disorder (GID)
Others
By Product
Software
Device
By Sales Channel
Business-to-business (B2B)
Employer
Healthcare Provider
Others
Business-to-consumer (B2C)
Patient
Caregiver
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2017
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in adoption of smartphone and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns
3.4.3. Opportunity
3.4.3.1. Emerging markets offer significant growth opportunities
CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Diabetes
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Obesity
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Cardiovascular diseases
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Central nervous system (cns) diseases
4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Gastrointestinal disorder
4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Respiratory diseases
4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Smoking cessation
4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Others
4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Software
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Devices
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Business-To-Business (b2b)
6.2.1. Market size and forecast, by type
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Employer
6.2.4.1. Market size and forecast
6.2.5. Healthcare Providers
6.2.5.1. Market size and forecast
6.2.6. Others
6.2.6.1. Market size and forecast
6.3. Business-to-consumers
6.3.1. Market size and forecast, by type
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Patients
6.3.4.1. Market size and forecast
6.3.5. Caregivers
6.3.5.1. Market size and forecast
CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North america
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country
7.2.2.1. U.S. digital therapeutics market by application
7.2.2.2. U.S digital therapeutics market by product type
7.2.2.3. U.S. digital therapeutics market by sales channel
7.2.2.4. Canada digital therapeutics market by application
7.2.2.5. Canada digital therapeutics market by product type
7.2.2.6. Canada digital therapeutics market by sales channel
7.2.2.7. Mexico digital therapeutics market by application
7.2.2.8. Mexico digital therapeutics market by product type
7.2.2.9. Mexico digital therapeutics market by sales channel
7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country
7.3.2.1. UK digital therapeutics market by application
7.3.2.2. UK digital therapeutics market by product type
7.3.2.3. UK digital therapeutics market by sales channel
7.3.2.4. Germany digital therapeutics market by application
7.3.2.5. Germany digital therapeutics market by product type
7.3.2.6. Germany digital therapeutics market by sales channel
7.3.2.7. France digital therapeutics market by application
7.3.2.8. France digital therapeutics market by product type
7.3.2.9. France digital therapeutics market by sales channel
7.3.2.10. Italy digital therapeutics market by application
7.3.2.11. Italy digital therapeutics market by product type
7.3.2.12. Italy digital therapeutics market by sales channel
7.3.2.13. Spain digital therapeutics market by application
7.3.2.14. Spain digital therapeutics market by product type
7.3.2.15. Spain digital therapeutics market by sales channel
7.3.2.16. Rest of Europe digital therapeutics market by application
7.3.2.17. Rest of Europe digital therapeutics market by product type
7.3.2.18. Rest of Europe digital therapeutics market by sales channel
7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel
7.4. Asia-pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country
7.4.2.1. Japan digital therapeutics market by application
7.4.2.2. Japan digital therapeutics market by product type
7.4.2.3. Japan digital therapeutics market by sales channel
7.4.2.4. China digital therapeutics market by application
7.4.2.5. China digital therapeutics market by product type
7.4.2.6. China digital therapeutics market by sales channel
7.4.2.7. Australia digital therapeutics market by application
7.4.2.8. Australia digital therapeutics market by product type
7.4.2.9. Australia digital therapeutics market by sales channel
7.4.2.10. India digital therapeutics market by application
7.4.2.11. India digital therapeutics market by product type
7.4.2.12. India digital therapeutics market by sales channel
7.4.2.13. South Korea digital therapeutics market by application
7.4.2.14. South Korea digital therapeutics market by product type
7.4.2.15. South Korea digital therapeutics market by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market by sales channel
7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country
7.5.2.1. Brazil digital therapeutics market by application
7.5.2.2. Brazil digital therapeutics market by product type
7.5.2.3. Brazil digital therapeutics market by sales channel
7.5.2.4. Turkey digital therapeutics market by application
7.5.2.5. Turkey digital therapeutics market by product type
7.5.2.6. Turkey digital therapeutics market by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market by application
7.5.2.8. Saudi Arabia digital therapeutics market by product type
7.5.2.9. Saudi Arabia digital therapeutics market by sales channel
7.5.2.10. South Africa digital therapeutics market by application
7.5.2.11. South Africa digital therapeutics market by product type
7.5.2.12. South Africa digital therapeutics market by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market by application
7.5.2.14. Rest of LAMEA digital therapeutics market by product type
7.5.2.15. Rest of LAMEA digital therapeutics market by sales channel
7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel
CHAPTER 8: COMPANY PROFILES
8.1. PROTEUS DIGITAL HEALTH, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. OMADA HEALTH, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. WELLDOC, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Key strategic moves and developments
8.4. 2 MORROW INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. LIVONGO HEALTH
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. PROPELLER HEALTH
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. TWINE HEALTH, INC. (FITBIT INC.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. CANARY HEALTH, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NOOM INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. MEDTRONIC PLC
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
